A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs

Molecular and Cellular Biology

Volumn 32, Issue 18, 2012, Pages 3648-3662

  Hoverter, Nate P ^a   Ting, Ju Hui ^a,c   Sundaresh, Suman ^b,d   Baldi, Pierre ^b   Waterman, Marian L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ringgold Standard Institution Informatics   (United States)

^c ACADEMIA SINICA   (Taiwan)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOID ENHANCER FACTOR 1; MUTANT PROTEIN; PROTEIN P21; T CELL FACTOR PROTEIN; WNT PROTEIN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC TRANSCRIPTION; HIGH MOBILITY GROUP BOX DOMAIN; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA STABILITY;

CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; RESPONSE ELEMENTS; T CELL TRANSCRIPTION FACTOR 1; TRANSCRIPTION, GENETIC; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84866406403     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06769-11     Document Type: Article

References (78)

1. Angus-Hill ML, Elbert KM, Hidalgo J, Capecchi MR. 2011. T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 108:4914-4919.
2. Arce L, Yokoyama NN, Waterman ML. 2006. Diversity of LEF/TCF action in development and disease. Oncogene 25:7492-7504.
3. Atcha FA, Munguia JE, Li TW, Hovanes K, Waterman ML. 2003. A new beta-catenin-dependent activation domain in T cell factor. J. Biol. Chem. 278:16169-16175.
4. Atcha FA, et al. 2007. A unique DNA binding domain converts T-cell factors into strong Wnt effectors. Mol. Cell Biol. 27:8352-8363.
5. Bai YQ, Miyake S, Iwai T, Yuasa Y. 2003. CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene. Oncogene 22:7942-7949.
6. Baldi P, Long AD. 2001. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 17:509-519.
7. Barker N, et al. 2009. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457:608-611.
8. Battelli C, Nikopoulos GN, Mitchell JG, Verdi JM. 2006. The RNAbinding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1. Mol. Cell Neurosci. 31:85-96.
9. Beland M, et al. 2004. Cdx1 autoregulation is governed by a novel Cdx1-LEF1 transcription complex. Mol. Cell. Biol. 24:5028-5038.
10. Blache P, et al. 2004. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J. Cell Biol. 166:37-47.
11. Boon EM, van der Neut R, van de Wetering M, Clevers H, Pals ST. 2002. Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer. Cancer Res. 62:5126-5128.
12. Bottomly D, Kyler SL, McWeeney SK, Yochum GS. 2010. Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res. 38:5735-5745.
13. Buttitta L, Tanaka TS, Chen AE, Ko MS, Fan CM. 2003. Microarray analysis of somitogenesis reveals novel targets of different WNT signaling pathways in the somitic mesoderm. Dev. Biol. 258:91-104.
14. Camargo FD, et al. 2007. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17:2054-2060.
15. Chang MV, Chang JL, Gangopadhyay A, Shearer A, Cadigan KM. 2008. Activation of wingless targets requires bipartite recognition of DNA by TCF. Curr. Biol. 18:1877-1881.
16. Chen Y, et al. 2006. Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers. Biochem. Biophys. Res. Commun. 340:758-766.
17. Choe SE, Boutros M, Michelson AM, Church GM, Halfon MS. 2005. Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset. Genome Biol. 6:R16. doi:10.1186/gb-2005-6-2-r16.
18. Clevers H. 2006. Wnt/beta-catenin signaling in development and disease. Cell 127:469-480.
19. Crissey MA, et al. 2008. The homeodomain transcription factor Cdx1 does not behave as an oncogene in normal mouse intestine. Neoplasia 10:8-19.
20. Dehner M, Hadjihannas M, Weiske J, Huber O, Behrens J. 2008. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum-and glucocorticoid-inducible kinase 1. J. Biol. Chem. 283:19201-19210.
21. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
22. Finch AJ, Soucek L, Junttila MR, Swigart LB, Evan GI. 2009. Acute overexpression of Myc in intestinal epithelium recapitulates some but not all the changes elicited by Wnt/beta-catenin pathway activation. Mol. Cell. Biol. 29:5306-5315.
23. Fujimura N, et al. 2007. Wnt-mediated down-regulation of Sp1 target genes by a transcriptional repressor Sp5. J. Biol. Chem. 282:1225-1237.
24. Gaur T, et al. 2005. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280:33132-33140.
25. George RJ, et al. 2009. Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury. Am. J. Physiol. Gastrointest. Liver Physiol. 296:G245-254.
26. Giese K, Pagel J, Grosschedl R. 1997. Functional analysis of DNA bend-ing and unwinding by the high mobility group domain of LEF-1. Proc. Natl. Acad. Sci. U. S. A. 94:12845-12850.
27. waf1 gene. Oncogene 23:7391-7398.
28. Hatfield GW, Hung SP, Baldi P. 2003. Differential analysis of DNA microarray gene expression data. Mol. Microbiol. 47:871-877.
29. Hatzis P, et al. 2008. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol. Cell. Biol. 28:2732-2744.
30. Hauck L, et al. 2007. Critical role for FoxO3a-dependent regulation of p21CIP1/WAF1 in response to statin signaling in cardiac myocytes. Circ. Res. 100:50-60.
31. He TC, et al. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
32. Hecht A, Stemmler MP. 2003. Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4. J. Biol. Chem. 278:3776-3785.
33. Higuchi R, Krummel B, Saiki RK. 1988. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 16:7351-7367.
34. Hoi CS, et al. 2010. Runx1 directly promotes proliferation of hair follicle stem cells and epithelial tumor formation in mouse skin. Mol. Cell. Biol. 30:2518-2536.
35. Hoogaars WM, et al. 2008. TBX3 and its splice variant TBX3 + exon 2a are functionally similar. Pigment Cell Melanoma Res. 21:379-387.
36. Hovanes K, et al. 2001. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat. Genet. 28:53-57.
37. Hung SP, Baldi P, Hatfield GW. 2002. Global gene expression profiling in Escherichia coli K-12: the effects of leucine-responsive regulatory protein. J. Biol. Chem. 277:40309-40323.
38. Ioannidis P, et al. 1999. The polyadenylation inhibitor cordycepin (3=dA) causes a decline in c-MYC mRNA levels without affecting c-MYC protein levels. Oncogene 18:117-125.
39. Irizarry RA, et al. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31:e15.
40. Irizarry RA, et al. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
41. Jubb AM, et al. 2006. Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia. Oncogene 25:3445-3457.
42. Katoh M. 2006. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int. J. Mol. Med. 17:681-685.
43. Kim JS, et al. 2002. Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res. 62:2744-2748.
44. Kioussi C, et al. 2002. Identification of a Wnt/Dvl/beta-catenin ¡ Pitx2 pathway mediating cell-type-specific proliferation during development. Cell 111:673-685.
45. Konsavage WM, Jr, Kyler SL, Rennoll SA, Jin G, Yochum GS. 2012. Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J. Biol. Chem. 287:11730-11739.
46. Korinek V, et al. 1998. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19:379-383.
47. Kosinski C, et al. 2007. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc. Natl. Acad. Sci. U. S. A. 104:15418-15423.
48. Li L, Clevers H. 2010. Coexistence of quiescent and active adult stem cells in mammals. Science 327:542-545.
49. Lickert H, et al. 2000. Wnt/(beta)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine. Development 127:3805-3813.
50. Liu Y, Lagowski JP, Vanderbeek GE, Kulesz-Martin MF. 2004. Facilitated search for specific genomic targets by p53 C-terminal basic DNA binding domain. Cancer Biol. Ther. 3:1102-1108.
51. Liu ZM, Huang HS. 2008. Inhibitory role of TGIF in the As2O3-regulated p21 WAF1/CIP1 expression. J. Biomed. Sci. 15:333-342.
52. Love JJ, et al. 1995. Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376:791-795.
53. Lustig B, et al. 2002. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 22:1184-1193.
54. McKinney K, Mattia M, Gottifredi V, Prives C. 2004. p53 linear diffusion along DNA requires its C terminus. Mol. Cell 16:413-424.
55. Meyer N, Penn LZ. 2008. Reflecting on 25 years with MYC. Nat. Rev. Cancer 8:976-990.
56. Miranda-Carboni GA, et al. 2008. A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors. Genes Dev. 22:3121-3134.
57. Moskaluk CA, et al. 2003. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod. Pathol. 16:913-919.
58. Moucadel V, et al. 2002. The homeobox gene Cdx1 belongs to the p53-p21(WAF)-Bcl-2 network in intestinal epithelial cells. Biochem. Biophys. Res. Commun. 297:607-615.
59. Najdi R, et al. 2009. A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer. Oncogene 28:4133-4146.
60. Nakshatri H, et al. 2000. The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2. Biochem. Biophys. Res. Commun. 270:1144-1153.
61. Nishitani H, et al. 2008. CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J. Biol. Chem. 283:29045-29052.
62. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R. 2005. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat. Immunol. 6:1054-1060.
63. Polakis P. 2000. Wnt signaling and cancer. Genes Dev. 14:1837-1851.
64. Ren F, et al. 2010. Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc. Natl. Acad. Sci. U. S. A. 107:21064-21069.
65. Renard CA, et al. 2007. Tbx3 is a downstream target of the Wnt/betacatenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Cancer Res. 67:901-910.
66. Roose J, et al. 1999. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285:1923-1926.
67. Segditsas S, et al. 2008. Putative direct and indirect Wnt targets identified through consistent gene expression changes in APC-mutant intestinal adenomas from humans and mice. Hum. Mol. Genet. 17:3864-3875.
68. Shin SW, et al. 2009. Clinical significance of chicken ovalbumin upstream promoter-transcription factor II expression in human colorectal cancer. Oncol. Rep. 21:101-106.
69. Van der Flier LG, et al. 2007. The intestinal Wnt/TCF signature. Gastroenterology 132:628-632.
70. van de Wetering M, Castrop J, Korinek V, Clevers H. 1996. Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties. Mol. Cell. Biol. 16:745-752.
71. van de Wetering M, et al. 1997. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88:789-799.
72. van de Wetering M, et al. 2002. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250.
73. Watt KI, et al. 2010. Yap is a novel regulator of C2C12 myogenesis. Biochem. Biophys. Res. Commun. 393:619-624.
74. Weise A, et al. 2010. Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets. Nucleic Acids Res. 38: 1964-1981.
75. Westendorf JJ, et al. 2002. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol. Cell. Biol. 22:7982-7992.
76. Wright WE, Binder M, Funk W. 1991. Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol. Cell. Biol. 11:4104-4110.
77. Yang WC, et al. 2001. Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res. 61:565-569.
78. Zirbes TK, et al. 2000. Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int. J. Cancer 89:14-18.